Search results
The path to a better tuberculosis vaccine runs through Montana
Medical Xpress· 3 hours agoA team of Montana researchers is playing a key role in the development of a more effective vaccine...
FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies
Benzinga via Yahoo Finance· 6 days agoThe drug is combined with the BCG vaccine, mainly used against tuberculosis and as a common...
US FDA approves ImmunityBio's bladder cancer therapy
Reuters via Yahoo News· 7 days ago(Reuters) -The U.S. health regulator approved on Monday ImmunityBio's combination therapy to treat a type of bladder cancer, marking an end to the...
ImmunityBio stock jumps as FDA clears bladder cancer therapy (NASDAQ:IBRX)
Seeking Alpha· 6 days agoShares of ImmunityBio (IBRX) surged 33% premarket after FDA clearance of its combination therapy for...
First-in-class IL-15 receptor agonist nabs FDA approval for bladder cancer
Nature· 4 days agoDiscover the world’s best science and medicine | Nature.com